123 related articles for article (PubMed ID: 6750238)
21. [Ewing's sarcoma of bone. Present state of its morphological diagnosis].
Schulz A; Jundt G; Alles JU; Altmannsberger M
Pathologe; 1984 Mar; 5(2):63-72. PubMed ID: 6425818
[No Abstract] [Full Text] [Related]
22. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of a cell line from a human gliosarcoma.
Rutka JT; Giblin JR; Høifødt HK; Dougherty DV; Bell CW; McCulloch JR; Davis RL; Wilson CB; Rosenblum ML
Cancer Res; 1986 Nov; 46(11):5893-902. PubMed ID: 3019542
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Sakai A; Ochi M
Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
[TBL] [Abstract][Full Text] [Related]
25. Tissue culture as a diagnostic technique for soft-tissue sarcoma of childhood.
Garvin AJ; Drew SW; Hintz DS; Sens DA
Arch Pathol Lab Med; 1984 Apr; 108(4):308-10. PubMed ID: 6546671
[TBL] [Abstract][Full Text] [Related]
26. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
[TBL] [Abstract][Full Text] [Related]
27. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
28. [Biopathology of Ewing's sarcoma].
Llombart-Bosch A; Carda K; Peydro-Olaya A
Arkh Patol; 1994; 56(6):37-44. PubMed ID: 7605216
[TBL] [Abstract][Full Text] [Related]
29. In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.
Gabor F; Wollmann K; Theyer G; Haberl I; Hamilton G
Anticancer Res; 1994; 14(5A):1943-50. PubMed ID: 7847832
[TBL] [Abstract][Full Text] [Related]
30. Characterization of intermediate filaments expressed by Ewing tumor cell lines.
Dellagi K; Lipinski M; Paulin D; Portier MM; Lenoir GM; Brouet JC
Cancer Res; 1987 Feb; 47(4):1170-3. PubMed ID: 2433034
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructure of Ewing's sarcoma of the bone.
Sirsat SM; Panicker KN; Potdar GG
Indian J Cancer; 1971 Sep; 8(3):157-62. PubMed ID: 5141720
[No Abstract] [Full Text] [Related]
32. [Ewing's sarcoma and related conditions].
Franchi A
Pathologica; 2000 Apr; 92(2):123-5. PubMed ID: 10838882
[No Abstract] [Full Text] [Related]
33. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.
Garg V; Zhang W; Gidwani P; Kim M; Kolb EA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5446-54. PubMed ID: 17875774
[TBL] [Abstract][Full Text] [Related]
34. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.
Teitell MA; Thompson AD; Sorensen PH; Shimada H; Triche TJ; Denny CT
Lab Invest; 1999 Dec; 79(12):1535-43. PubMed ID: 10616204
[TBL] [Abstract][Full Text] [Related]
35. Ewing's sarcoma of the nose.
Howard DJ; Daniels HA
Ear Nose Throat J; 1993 Apr; 72(4):277-9. PubMed ID: 8486106
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM
Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
[TBL] [Abstract][Full Text] [Related]
37. [Immunocytologic study of light cell lines established in vitro from Ewing's sarcoma. Identification of neural markers].
Lizard-Nacol S; Justrabo E; Mugneret F; Volk C; Turc-Carel C
C R Seances Soc Biol Fil; 1988; 182(1):118-25. PubMed ID: 2972341
[TBL] [Abstract][Full Text] [Related]
38. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.
Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K
Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736
[TBL] [Abstract][Full Text] [Related]
39. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo.
Zhou Z; Reddy K; Guan H; Kleinerman ES
Mol Cancer Res; 2007 Nov; 5(11):1125-32. PubMed ID: 18025258
[TBL] [Abstract][Full Text] [Related]
40. Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.
Jia SF; Duan X; Worth LL; Guan H; Kleinerman ES
Cancer Gene Ther; 2006 Oct; 13(10):948-57. PubMed ID: 16763609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
